Core Viewpoint - The Shimao Tower in Beijing's Chaoyang District was sold at a significant discount, raising questions about the implications of a pharmaceutical company, Yangtze River Pharmaceutical Group, entering the real estate market and the current situation of Shimao Group after multiple asset disposals [1][5]. Group 1: Transaction Details - The Shimao Tower was auctioned for 2.254 billion yuan, which is approximately 70% of its latest assessed value of 3.22 billion yuan [3][4]. - The buyer, Beijing Yangtze River Real Estate Co., Ltd., is a wholly-owned subsidiary of Yangtze River Pharmaceutical Group, which was established in late October 2023 [3][4]. - The building, completed in 2006, has a total area of 70,000 square meters and is located in a prime business district near major transportation and luxury amenities [3][4]. Group 2: Yangtze River Pharmaceutical Group Overview - Yangtze River Pharmaceutical Group, founded in 1971, is a leading player in the domestic pharmaceutical industry, with projected revenues of 73.93 billion yuan in 2024, ranking first among private pharmaceutical companies [4]. - The company has a gross margin of approximately 65% and a net margin of about 18%, both exceeding industry averages [4]. - The group is expanding its footprint in the real estate sector as part of its broader strategy to develop a health management ecosystem, with ongoing projects in key regions [4][5]. Group 3: Shimao Group's Current Situation - Shimao Group, once known for its luxury real estate developments, has been selling assets to recover funds after declaring a default on a $1 billion overseas debt in July 2022 [6][7]. - The company has sold various landmark properties and has been actively restructuring its overseas debt, which amounts to approximately $14.4 billion [7][8]. - In the first half of 2023, Shimao Group reported revenues of 14.827 billion yuan, with a net loss of 8.934 billion yuan, indicating a significant reduction in losses compared to the previous year [8][9].

Core Viewpoint - Yangtze River Pharmaceutical Group's subsidiary acquired the Beijing Shimao Building for 2.254 billion yuan, significantly below its appraised value of 3.22 billion yuan, indicating a strategic investment opportunity in the real estate sector [1] Group 1: Acquisition Details - The property auctioned includes a commercial building with a total construction area of 70,174 square meters located in Chaoyang District, Beijing [1] - The starting price for the auction was set at 2.254 billion yuan, and the final transaction price represented a 30% discount from the appraised value [1] Group 2: Company Background - Beijing Yangtze River Real Estate Co., Ltd. is a wholly-owned subsidiary of Yangtze River (Guangdong Hengqin) Health Investment Co., Ltd., which is fully owned by Yangtze River Pharmaceutical Group [1]

FF301 本月底法定/註冊股本總額： HKD 2,500,000,000 第 1 頁 共 10 頁 v 1.1.1 致：香港交易及結算所有限公司 公司名稱: 世茂集團控股有限公司（於開曼群島註冊成立之有限公司） 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00813 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 25,000,000,000 | HKD | | 0.1 HKD | | 2,500,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | ...

Core Viewpoint - Shimao Group (00813) announced that its subsidiary, Shanghai Shimao Co., Ltd., achieved a revenue of 4.292 billion yuan in the first three quarters of 2025, representing a year-on-year growth of 7.65% [1] Financial Performance - The revenue for the first three quarters of 2025 reached 4.292 billion yuan [1] - This figure indicates a year-on-year increase of 7.65% [1]

智通财经APP讯，世茂集团(00813)发布公告，公司附属公司上海世茂股份有限公司于2025年前三季度取 得营业收入42.92亿元，同比增长7.65%。 ...

（於開曼群島註冊成立之有限公司） （股份代號：813） 海外監管公告 世茂集團控股有限公司的附屬公司 上海世茂股份有限公司 截至 2025 年 9 月 30 日止九個月之未經審核財務業績公告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全 部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | 2025年9月30日 | 2024年12月31日 | | --- | --- | --- | | | 人民幣 | 人民幣 | | 資產 | | | | 流動資產 | 36,092,664,068.43 | 42,773,424,656.82 | | 非流動資產 | 30,855,184,100.81 | 33,222,483,968.89 | | 資產合計 | 66,947,848,169.24 | 75,995,908,625.71 | | 負債及股東權益 | | | | 流動負債 | 61,133,818,705.55 | 66,011,418,358.40 | | 非流動負債 | 10,032,533 ...

世茂集团(00813)发布公告，于2025年10月21日根据于2025年7月21日所发行的2026年到期零息强制可换 股债券的转换而配发及发行5.71亿股。 ...

Core Viewpoint - Shimao Group (00813) announced the issuance of 571 million shares as a result of the conversion of zero-coupon mandatory convertible bonds maturing in 2026, which were issued on July 21, 2025 [1] Group 1 - The conversion of the bonds will take place on October 21, 2025 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 世茂集團控股有限公司 呈交日期： 2025年10月21日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 00813 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | | | 佔有關事件前的現有已發 | | | 每股發行/出售價 ...

Core Insights - The real estate market in September showed signs of stabilization and recovery, driven primarily by the demand for improved housing options [1][9] - A total of 24 real estate companies reported sales data, with 15 companies, accounting for 62.5%, experiencing a month-on-month increase in sales [1] - Differentiated pricing strategies have played a crucial role, with smaller units attracting buyers through competitive pricing, while improved housing options achieved premium pricing [1][9] Sales Performance - Among the 24 companies, Poly Developments and China Overseas Development led with sales exceeding 200 billion yuan in September, at 205.31 billion yuan and 201.73 billion yuan respectively [3] - Other notable companies include China Resources Land and China Merchants Shekou, with sales of 176 billion yuan and 166.98 billion yuan [3] - The sales growth for Poly Developments and China Overseas has been consistent, with both companies reporting month-on-month increases for three consecutive months [3] Market Dynamics - Different tiers of companies are experiencing varied recovery rates, with top-tier firms benefiting from scale advantages and mid-tier firms leveraging popular projects to boost sales [3][4] - Companies like R&F Properties saw a significant month-on-month increase of 132.31% in September due to a low sales base in August [4] - The overall market recovery is supported by strong land acquisition strategies focused on first- and second-tier cities, with a reported 13% year-on-year increase in land sales revenue across 300 cities [5] Land Acquisition Trends - Real estate companies are increasingly concentrating their land acquisitions in core cities, with top 20 cities accounting for 61% of the total land sales revenue [5] - China Resources Land acquired 18 new projects in the first half of 2025, with a total investment of 32.28 billion yuan, primarily in first- and second-tier cities [5] - The supply of quality land has increased, providing more options for developers, as seen in Beijing's recent addition of 22 new real estate projects [6] Product Quality and Market Appeal - The introduction of high-quality housing standards has enhanced market attractiveness, with improved housing options meeting the needs of buyers [7] - Recent policy adjustments in major cities have further stimulated demand, allowing for greater flexibility in purchasing [7] - The sales of improved housing options have surged, with a notable increase in the proportion of larger units sold in major cities [8][9]